Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Biotechnology

Healthcare
$39.15 +8.79%

+$2.32 today

Market cap
$1.83B
Beta
0.00
52W Low $23.00High $36.61

Volume 0.30M

Average 0.34M

COAG Property, Plant & Equipment (Net)

Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.

Hemab Therapeutics Holdings, Inc. Common StockNASDAQ: COAG

Property, Plant & Equipment (Net) · Q2 FY2026 · quarter ended Jun 2026

Property, plant & equipment (net) of $1.5M in Q2 FY2026

Q2 FY2026 property, plant & equipment (net) was $1.5M.

Context

  • Property, plant & equipment (net) amounted to 0.3% of total assets at the end of Q2 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.5M-5.7% QoQ
Last fiscal yearDec 2025
$1.7M— YoY
Property, Plant & Equipment (Net) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Property, Plant & Equipment (Net) history

USD · from the balance sheet

Latest · FY2025
1.7M USD
Year-over-year change
—

Property, Plant & Equipment (Net) vs competitors

How COAG compares with its peers on the latest reported figures

  • COAG's Jun 2026 property, plant & equipment (net) of $1.5M is the 3rd highest of the 5 companies compared; the peer median is $879.5K.
  • Property, plant & equipment (net) amounts to 0.3% of total assets for COAG, versus a peer median of 0.3%.
COAG Competitors Peer median
Property, Plant & Equipment (Net) for COAG and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
QUREuniQure N.V.Mar 2026$24.28M -23.1%-31.9%3.1%
IRONDisc Medicine, Inc.Sep 2026$1.59M -35.2%+12.2%0.2%
COAGHemab Therapeutics Holdings, Inc. Common StockJun 2026$1.5M ——0.3%
RLYBRallybio CorporationMar 2026$172K -9.0%-39.8%0.3%
DMRADamora Therapeutics, Inc.Mar 2026$0 -100.0%-55.3%0.0%
Peer median (excluding COAG) $879.5K-29.1%-35.9%0.3%

Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Hemab Therapeutics Holdings, Inc. Common Stock

NASDAQ:COAG

Intrinsic Alpha fair value

Locked

Current Price

$39.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.